Ryan Spanheimer

Ryan Spanheimer is a practicing patent attorney and an investor at Engage Venture Partners, a venture capital firm based in Minneapolis, Minnesota. He co-founded the investment firm in 2022 to facilitate seed to Series A capital deployments in early-stage medical technology ventures through the use of special purpose vehicles. Spanheimer has been involved in at least eight past financial transactions, which includes backing the medical device company Laplace Interventional during its Series C funding round. Concurrently, he serves as a patent attorney at the law firm Fredrikson & Byron, where he specializes in patent acquisition, portfolio management, and freedom-to-operate analyses for industrial and healthcare clients. His dual professional background allows him to execute intellectual property due diligence and guide commercialization strategies for emerging medical device, digital health, and healthcare IT companies across the Midwest.